foxo4 dri structure FOXO4-DRI FOXO4 -DRI (10MG)INJECTION, Packaging Type:
Description
Cheng, L
S.CollinsJ
After reconstitution, refrigerate at 28C and use within 812 weeks
As of 2024, the MHRA (Medicines and Healthcare products Regulatory Agency) has authorised Mounjaro for use in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity, such as hypertension, dyslipidaemia, or obstructive sleep apnoea
